Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Shire to co-develop three Amicus compounds

FOLD and Shire (LSE:SHP; SHPGY) partnered to jointly develop FOLD's Amigal migalastat, Plicera isofagomine tartrate and

Read the full 165 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE